UNIFORMED SERVICES UNIVERSITY 
BETHESDA, MARYLAND 20814 
HEALTH SCIENCES 
SCHOOL OF MEDICINE 
4301 JONES BRIDGE ROAD 
OF THE 
INSTRUCTIONAL AND 
RESEARCH SUPPORT 
14 December 1982 
TEACHING HOSPITALS 
WALTER REED ARMY MEDICAL CENTER 
NATIONAL NAVAL MEDICAL CENTER 
MALCOLM GROW AIR FORCE MEDICAL CENTER 
WILFORD HALL AIR FORCE MEDICAL CENTER 
William J. Gartland, Jr., Ph.D. 
Office of Recombinant DNA Activities 
NIH, Building 31, Room 4A52 
Bethesda, Maryland 20205 
Si r : 
Reference your memorandum, "Solicitation of Comments on Revised Guidelines 
for Research Involving Recombinant DNA Molecules", attached. 
A survey form was forwarded to all investigators involved with recombinants 
here at USUHS. The same questions per your memorandum were presented as 
was a request for general comments. On the whole, the investigators 
indicated that they had no problems with the Guidelines as they impacted 
on their research. 
USUHS has two committees which address biosafety. The Biohazards, Controlled 
Substances, and Dangerous Materials (BCD) Committee reviews new protocols 
through distribution of said protocols to individual members. There are 
committee augmentees who review protocols involving recombinants. This 
committee will meet only when a major problem arises with a proposed project 
requiring discussion and resolution. 
The second involved committee is the Biohazard Suite Committee which 
establishes policy and monitors use of the new P-3 containment facility 
here at the institution. Since the suite has just been rendered operational, 
the committee is planning only its second meeting. Frequency of meetings 
will be dependent upon encountered problems or procedural changes. 
If further information is required d at 295-3305. 
Richard X. Riccardi, C.I.H. 
Lt Col/USAF, BSC 
Director, Environmental Health 
and Occupational Safety 
Attachment 
[ 553 ] 
